Key result
Autonomic regulation therapy with chronic vagus nerve stimulation reduced peak T-wave alternans levels from 71.0 to 50.5 μV (P<.0001) at 12 months in patients with chronic heart failure.
Why the study?
Does autonomic regulation therapy with chronic vagus nerve stimulation improve quantitative T-wave alternans and baroreflex sensitivity in patients with chronic symptomatic heart failure and reduced ejection fraction?
Does autonomic regulation therapy with chronic vagus nerve stimulation improve quantitative T-wave alternans and baroreflex sensitivity in patients with chronic symptomatic heart failure and reduced ejection fraction?
Absolute Event Rate: 50.5% vs 71%
p-value: p=<.0001
Chronic autonomic regulation therapy with vagus nerve stimulation significantly reduces T-wave alternans and nonsustained ventricular tachycardia while improving baroreflex sensitivity in patients with HFrEF.
BACKGROUND: Autonomic regulation therapy (ART) with chronic vagus nerve stimulation improves ventricular function in patients with chronic heart failure, but its effects on quantitative T-wave alternans (TWA), ventricular tachycardia (VT), baroreflex sensitivity, and autonomic tone remained unknown. OBJECTIVE: Effects on TWA, a marker of risk of life-threatening arrhythmias; heart rate turbulence (HRT), an indicator of baroreflex sensitivity; heart rate variability; and VT incidence were studied in 25 patients with chronic symptomatic heart failure and reduced ejection fraction enrolled in the ANTHEM-HF study (NCT01823887). METHODS: Twenty-four-hour ambulatory electrocardiographic recordings made before ART system (Cyberonics, Inc., Houston, TX) implantation involving the left or right vagus nerve and after 6 and 12 months of chronic therapy (10-Hz frequency, 250-μs pulse width, maximum tolerable current amplitude after 10 weeks of titration) at low-intensity (<2 mA; n = 10, 40%) or high-intensity (≥2 mA; n = 15, 60%) stimulation levels were analyzed. RESULTS: At 12 months, peak TWA levels were reduced by 29% from 71.0 ± 4.6 to 50.5 ± 1.8 μV (P < .0001). The number of patients with severely abnormal TWA (≥60 μV) was reduced by 76% from 17 to 4 (P < .0005), and the number of patients with nonsustained VT decreased by 73% from 11 to 3 (P < .025). HRT slope (P < .025), high frequency heart rate variability (HRV) (P = .05), and square root of the mean squared differences of successive normal-to-normal interval HRV (P = .013) increased. The mean heart rate derived from 24-hour Holter electrocardiograms decreased by 10% from 77 ± 2 to 69 ± 2 beats/min (P = .0002). HRT onset was unchanged. CONCLUSION: Chronic ART in patients with symptomatic heart failure improves cardiac electrical stability, as reflected by reduced TWA levels and heart rate, suppresses VT, and increases baroreceptor sensitivity. These observations deserve study in a larger population.
No takes yet. Share an insight, caveat, or question.
Libbus et al. (2015) studied chronic symptomatic heart failure and reduced ejection fraction (n=25). Autonomic regulation therapy (ART) with chronic vagus nerve stimulation vs. Baseline was evaluated on peak T-wave alternans (TWA) levels (p=<.0001). Autonomic regulation therapy with chronic vagus nerve stimulation reduced peak T-wave alternans levels from 71.0 to 50.5 μV (P<.0001) at 12 months in patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: